BioHealth News Archive
QIAGEN – Sample to Insight
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of OmicSoft Corporation, providing access to OmicSoft’s powerful multi-omics data management infrastructure…
Read MoreNIAID Awards Paragon Bioservices a Multiple Award IDIQ Contract valued up to $159M for Preclinical Drug Development Services
Paragon Bioservices received a multiple-award, indefinite-delivery, indefinite-quantity (IDIQ) contract to provide product development services for a variety of National Institute of Allergy and Infectious…
Read MoreEmergent BioSolutions to Support HHS Anthrax Preparedness Strategy With Up to $1 Billion in BioThrax Deliveries to the Strategic National Stockpile
Emergent BioSolutions Inc. (NYSE:EBS) today announced that the U.S. Department of Health and Human Services (HHS) is advancing its anthrax preparedness strategy with multiple…
Read MoreCuomo’s budget focuses on biotech, not nanotech – Times Union
Gov. Andrew Cuomo's state budget proposal puts most of its economic development bets on life sciences and biotech rather than semiconductors and nanotechnology. Cuomo's…
Read MoreWellDoc Receives FDA 510(k) Clearance to Offer a Non-Prescription Version of BlueStar® Digital Therapeutic for Type 2 Diabetes
Digital health leader WellDoc announced today that the U.S. Food and Drug Administration (FDA) has granted the Company 510(k) class II clearance for a…
Read MoreFebruary 7 Seminar in Collaboration with BDO & Crowell Moring
Tuesday, February 7, 20174:00 PM to 6:30 PM (Eastern)Institute for Bioscience & Biotechnology Research9600 Gudelsky Drive, Rockville, MD 20850 BDO and Crowell & Moring…
Read MoreRestoring a heartbeat with the help of a robot
Scientists have created a new soft robot that successfully reanimated several pigs’ hearts after they failed. The technology could one day keep an ailing…
Read MorePharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious
PharmAthene, Inc. (NYSE MKT: PIP) and Altimmune, Inc., a privately-held immunotherapeutics company targeting infectious diseases, announced today the signing of a definitive agreement for…
Read MoreBaltimore developer gets Trump administration tech post – Technical.ly Baltimore
One new member of President-elect Donald Trump’s administration is from Baltimore, and part of his job will involve tech policy. Reed Cordish, a real estate…
Read MoreMaryland Cybersecurity Awards Application | MDCyber.com
The Maryland Cybersecurity Awards Celebration is designed to honor the companies, organizations, and individuals that have protected businesses and government agencies with their cutting-edge…
Read More8 healthcare startup and investor trends at JPM17 from inverting business models to second order companies – MedCity News
Last week’s 35th annual J.P. Morgan Healthcare conference in San Francisco was packed with thousands of healthcare investors, analysts, large multinational healthcare companies, startups,…
Read MoreHere are the biggest stories from the J.P. Morgan Healthcare Conference – MedCity News
In a week that saw countless broken umbrellas and end to the Bay Area’s prolonged drought, the J.P. Morgan Healthcare conference in San Francisco featured…
Read MoreEpigenetics Drives Pancreatic Cancer Metastasis, Potentially Reversible – GEN
A multicenter study led by investigators at Johns Hopkins University just reported on a full genomic analysis of tumor samples from a small number…
Read MoreJan 31 NHLBI Small Biz Hangout: Perfecting Your Pitch
Tuesday, January 31 at 2:00 PM ET You’ve got an amazing idea for a new medical product, it’ll save lives, speed recovery, be less…
Read MoreOne Man’s Quest to Hack His Own Genes
In a dream Brian Hanley told me about, he’s riding a bus when he meets a man in dark leather clothing. Next thing he…
Read More